Back to top
more

First Trust NASDAQ Pharmaceuticals ETF: (FTXH)

(Delayed Data from NASDAQ) As of Nov 1, 2024 01:09 PM ET

$28.38 USD

28.38
350

+0.11 (0.39%)

Volume: 350

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

2 - Buy of 5   2      

After-Market: $28.48 +0.10 (0.35 %) 7:58 PM ET

ETF Quote Details

Previous Close 28.27
Open 28.38
Bid 14.18
Ask 42.52
Day Low-High 28.38-28.38
52wk Low-High 23.85-29.72
Volume 350
NAV (month end) 28.84
Premium (+)/Discount (-) (month end)-0.57

Zacks Premium Research for FTXH

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

 Buy 2
ETF Risk

Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.

NA
ETF Report

ETF Expense Ratio

Expense Ratio 0.60%
Dividend (Yield) $0.44 (1.56%)
Issuer FIRST TRUST ADVISORS

Benchmark for FTXH

NASDAQ US SMART PHARMACEUTICALS INDEX

The Nasdaq US Smart Pharmaceuticals Index is a modified factor weighted index, designed to provide exposure to US companies within the pharmaceuticals industry.

Fund Summary for FTXH

FIRST TRUST NASDAQ PHARMACEUTICALS ETF

The First Trust Nasdaq Pharmaceuticals ETF seeks investment results that correspond generally to the price and yield, before fees and expenses, of the Nasdaq US Smart Pharmaceuticals Index.